Multiple defects of cell cycle checkpoints in U937-ASPI3K, an U937 cell mutant stably expressing anti-sense ATM gene cDNA

Abstract

(Ataxia-telangiectasia mutated gene (ATM) functions in control of cell cycle checkpoints in responding to DNA damage and protects cells from undergoing apoptosis. Knock-out within tumor cells of endogenous ATM will achieve therapeutic benefits and enable a better understanding of the decisive mechanisms of cell death or survival in response to DNA damaging agents.) In present paper, we sought to characterize the cell cycle checkpoint profiles in U937-ASPI3K, a U937 cell mutant that was previously established with endogenous ATM knock-out phenotype. Synchronized U937-ASPI3K was exposed to¹³⁷Cs irradiation, G₁, S, G₂/M cell cycle checkpoint profiles were evaluated by determining cell cycle kinetics, p53/p21 protein, cyclin dependent kinase 2 (CDK2) and p34CDC2 kinase activity in response to irradiation. U937-ASPI3K exhibited multiple defects in cell cycle checkpoints as defined by failing to arrest cells upon irradiation. The accumulation of cellular p53/p21 protein and inhibition of CDK kinase was also abolished in U937-ASPI3K. It was concluded that the stable expression of anti-sense PI3K cDNA fragment completely abolished multiple cell cycle checkpoints in U937-ASPI3K, and hence U937-ASPI3K with an AT-like phenotype could serves as a valuable model system for investigating the signal transduction pathway in responding to DNA damaging-based cancer therapy.

Keywords

ataxia-telangiectasia mutated / ATM / cell cycle / apoptosis / cell cycle checkpoints

References

[1] HarndenD G. The nature of Ataxia-telangiectasia: problems and prospective. Int J Radiat Biol, 1994, 66(6): S13-S13

[2] SavitskyK A, Bar-shiraS, GiladG, et al.. A single ataxia-telangiectasia gene with a product similar to PI-3-Kinase. Science, 1995, 268: 1749-1749

[3] SavitskyK S, SfezD A, TagleA, et al.. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet, 1995, 4: 2025-2025

[4] ZhouJ F, LiuWenli, TangYi, et al.. Establish of a U937 cell line U937-ASPI3K. J EXP Hematology, 2000, 8(4): 280-280

[5] O’ConnorP M, FanS. DNA damage checkpoints: implications for cancer therapy. Progress in Cell cycle Res, 1996, 2: 165-165

[6] DarzynkiewiczZ. Apoptosis in antitumor strategies: modulation of cell cycle of differentiation. J Cell Biochem, 1995, 58: 151-151

[7] CarrA M. Checkpoints take the next step. Science, 1996, 271: 314-314

[8] Piwnica-WormsH. Cell cycle: Fools rush, 1999, 401: 535-535

[9] MorganS E, LovlyC, PanditaT K, et al.. Fragments of a ATM which have dominant-negative or complementing activity. Mol Cell Biol, 1997, 17: 2020-2020

[10] ShilohY, ParshadR, SanfordK K, et al.. Carrier detection in ataxia-telangiectasia. Lancet, 1986, 1: 689-689